Van Hollen, Scott Urge NASEM to Study Role of NIH in Drug Development and Patient Access
November 19, 2019
November 19, 2019
WASHINGTON, Nov. 19 -- Sen. Chris Van Hollen, D-Maryland, issued the following news release:
Today, U.S. Senators Chris Van Hollen (D-Md.) and Rick Scott (R-Fla.) wrote to the National Academies of Science, Engineering, and Medicine (NASEM) asking them to issue a report on its recent workshop examining the role of the National Institutes of Health (NIH) in the development of new drug treatments and the impact on patient access and pricing and issue a report. The Senators have introd . . .
Today, U.S. Senators Chris Van Hollen (D-Md.) and Rick Scott (R-Fla.) wrote to the National Academies of Science, Engineering, and Medicine (NASEM) asking them to issue a report on its recent workshop examining the role of the National Institutes of Health (NIH) in the development of new drug treatments and the impact on patient access and pricing and issue a report. The Senators have introd . . .